17.11M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection.

Similar securities

Based on sector and market capitalization

Report issue